GILD Daniel Patrick O'Day sells $17.3M worth of shares
Feb 07, 2026, 5:32 AM
0.00%
What does GILD do
Gilead Sciences, headquartered in Foster City, California, employs 18,000 people and focuses on developing medicines for HIV, hepatitis, COVID-19, and cancer. Its portfolio includes numerous marketed products and several promising candidates.
Daniel Patrick O'Day sold 115,640 shares of GILD on 5 February at $150.00 per share, worth a total of $17.3M. They now own 613,912 GILD shares, or a 16% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.